RHOJ and neoplasm: To assess whether Rhoj deletion affects the long-term response of tumours to chemotherapy, we transplanted EPCAM−Rhoj-WT and Rhoj-KO tumour cells into immunodeficient mice and treated mice presenting growing tumours with chemotherapy.